Symbol | Exchange | Currency |
|---|
Polarean Imaging PLC (LON:POLX) said the world-renowned University of Texas MD Anderson Cancer Center has now installed one of the company’s 9820 Xenon Polariser systems. The...
Polarean Imaging PLC (LON:POLX) is looking forward to furthering the global understanding of the COVID-19 medical case, it said in its 2020 results statement. The medical imaging...
Supply@ME Capital PLC (LON:SYME) said it agreed to buy TradeFlow Capital Management, a Singapore-based fintech-powered commodities trade enabler, in a cash and shares deal. ...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Sell | Strong Sell | Neutral |
| Technical Indicators | Strong Sell | Buy | Strong Buy | Strong Sell | Buy |
| Summary | Sell | Neutral | Neutral | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 38.50 | 38.50 | 38.50 | 0.00 | 0.00% | 4.25K | London | |||
| 49.25 | 47.20 | 47.20 | -4.30 | -8.35% | 5.54K | London | |||
| 124.00 | 124.00 | 124.00 | -0.50 | -0.40% | 303.57K | London | |||
| 31.50 | 31.80 | 31.80 | 0.00 | 0.00% | 13.52K | London | |||
| 355.00 | 356.00 | 345.50 | +10.00 | +2.90% | 169.66K | London | |||
| 107.00 | 108.00 | 100.20 | -1.00 | -0.92% | 3.62M | London | |||
| 106.50 | 107.00 | 106.00 | +0.50 | +0.47% | 47.38K | London | |||
| 5,976.00 | 5,976.00 | 5,848.00 | +118.0 | +2.01% | 640.00K | London | |||
| 456.00 | 461.00 | 450.50 | +2.50 | +0.55% | 470.43K | London | |||
| 4,725.00 | 4,806.50 | 4,725.00 | -41.5 | -0.87% | 2.09M | London | |||
| 294.50 | 297.50 | 285.00 | +7.00 | +2.44% | 148.15K | London | |||
| 1,797.50 | 1,832.00 | 1,763.50 | -29.50 | -1.61% | 1.23M | London | |||
| 337.50 | 355.00 | 336.00 | +5.00 | +1.50% | 200.61K | London | |||
| 1,700.00 | 1,702.00 | 1,700.00 | 0.00 | 0.00% | 0.00 | London | |||
| 2.995 | 2.995 | 2.995 | +0.8000 | +37.21% | 81.82M | London |
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of polarized Xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.